|
Match
|
Document |
Document Title |
|
|
US20090280198 |
Combined effects of nutrients on proliferation of stem cells
A method and composition for stimulating the proliferation and differentiation of stem cells is used to self-repair injury in mammals. A supplement is administered having an effective dose of...
|
|
|
US20090275540 |
Pre-Compacted Calcium-Containing Compositions
A pre-compacted materiel comprising one or more calcium-containing compounds and one or more sugar alcohols, wherein the calcium-containing compound having a polycrystallic porous structure. The...
|
|
|
US20090275515 |
2-HYDROXY-2-PHENYLTHIOPHENYLPROPIONAMIDES AS ANDROGEN RECEPTOR MODULATORS
Compounds of structural formula (I) are modulators of the androgen receptor (AR) in a tissue selective manner. These compounds are useful in the enhancement of weakened muscle tone and the...
|
|
|
US20090263508 |
MICRONUTRIENT SUPPLEMENT WITH CALCIUM, VITAMIN D OR CALCIUM & VITAMIN D COMBINATION FOR PREMENSTRUAL SYNDROME, POSTPARTUM DEPRESSION, DEPRESSION AND PANIC ATTACKS
A bolus dose supplement, foodstuff, beverage and beverage concentrate with calcium and vitamin D for the treatment and prevention of PMS, panic attacks, and postpartum depression. The combination...
|
|
|
US20090258845 |
Combination Dosage Forms and Therapies for Supporting Bone Health
Combined therapies and oral dosage forms based on genistein for the support of osteoporotic health.
|
|
|
US20090233889 |
STABILIZED 1,25-DIHYDROXYVITAMIN D2 AND METHOD OF MAKING SAME
A stabilized 1,25-dihydroxyvitamin D 2 composition which is particularly well suited for pharmaceutical formulations, pharmaceutical formulations of the 1,25-dihydroxyvitamin D 2 composition, and...
|
|
|
US20090227545 |
METHODS OF INCREASING EPIDERMAL SKIN THICKNESS BY TOPICAL ADMINISTRATION OF A 19-NOR CONTAINING VITAMIN D COMPOUND
Methods of increasing the thickness of the epidermal layer in the skin of a human comprising topically administering a therapeutically effective dose of an active pharmaceutical ingredient...
|
|
|
US20090221538 |
METHODS OF TREATING MULTIPLE SCLEROSIS BY ADMINISTERING PULSE DOSE CALCITRIOL
Prophylactic or therapeutic treatment to inhibit the development or progress of multiple sclerosis symptoms is provided by providing intermittently administered elevated doses of calcitriol,...
|
|
|
US20090221537 |
USE OF 25-HYDROXY VITAMIN D3 TO IMPROVE VITALITY OF ANIMALS
The present invention relates to the use of 25-hydroxy-vitamin D 3 to improve the general health status of female animals at least during gestation and/or lactation. The invention also relates to...
|
|
|
US20090221503 |
USE OF RAPAMYCIN AND RAPAMYCIN DERIVATIVES FOR THE TREATMENT OF BONE LOSS
The present invention relates to a new use of rapamycin and rapamycin derivatives.
|
|
|
US20090214661 |
PROCESS FOR THE PRODUCTION OF BEADLETS
A process for the production of cross-linked beadlets containing one or more active ingredients selected from the group of a fat-soluble vitamin active material, a carotenoid and a polyunsaturated...
|
|
|
US20090209501 |
METHOD OF TREATING AND PREVENTING SECONDARY HYPERPARATHYROIDISM
The a method of treating elevated blood levels of iPTH by increasing or maintaining blood concentrations of both 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in a patient by administering, as...
|
|
|
US20090209500 |
USE OF VITAMIN D RECEPTOR AGONISTS AND PRECURSORS TO TREAT FIBROSIS
This application relates to methods of treating, preventing, and ameliorating fibrosis, such as fibrosis of the liver, kidney, or pancreas. In particular, the application relates to methods of...
|
|
|
US20090196862 |
High dosage Vitamin D
A preparation containing vitamin D 3 (cholecalciferol), preferably an edible oil, in an amount of 200 IU to 20,000 IU, preferably 1000 IU to 5000 IU, and most preferably about 1500 IU to 3500 IU,...
|
|
|
US20090176749 |
OIL-IN-WATER EMULSION LOTION CONTAINING 22-OXA-1ALPHA, 25-DIHYDROXYVITAMIN D3 AND METHOD OF TREATMENT OF SKIN DISORDER USING THE SAME
Provided is a lotion that exhibits high percutaneous absorption inherent in maxacalcitol, allows the maxacalcitol to be stable, and exhibits less dripping when it is applied to heads. A basic...
|
|
|
US20090176748 |
METHODS AND COMPOSITIONS FOR CONTROLLED RELEASE ORAL DOSAGE OF A VITAMIN D COMPOUND
A stable, controlled release formulation for oral dosing of vitamin D compounds is disclosed. The formulation is prepared by incorporating one or more vitamin D compounds into a solid or semi-solid...
|
|
|
US20090170822 |
2-Methylene-20-Methyl-19,24,25,26,27-Pentanor-Vitamin D Analogs
This invention discloses 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin D analogs, and specifically 2-methylene-20-methyl-1α-hydroxy-19,24,25,26,27-pentanor-vi
tamin D 3 , and...
|
|
|
US20090170821 |
2-Methylene-(20S,25S)-19,26-Dinor-Vitamin D Analogs
This invention discloses 2-methylene-(20S,25S)-19,26-dinor-vitamin D analogs, and specifically 2-methylene-(20S,25S)-19,26-dinor-1α,25-dihydroxyvitamin D 3 , and pharmaceutical uses therefor. This...
|
|
|
US20090170820 |
2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs
This invention discloses 2-methylene-(20S,25R)-19,26-dinor-vitamin D analogs, and specifically 2-methylene-(20S,25R)-19,26-dinor-1α,25-dihydroxyvitamin D 3 , and pharmaceutical uses therefor. This...
|
|
|
US20090170819 |
(20R)-23,23-Difluoro-2-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs
This invention discloses (20R)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalcife
rol-vitamin D analogs, and specifically (20R)-23,23-difluoro-1...
|
|
|
US20090170818 |
(20S)-23,23-Difluoro-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs
This invention discloses (20S)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalcife
rol-vitamin D analogs, and specifically...
|
|
|
US20090169585 |
Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
The present invention relates to a resveratrol-containing composition capable of modulating gene expression to an extent greater than that observed with resveratrol alone or with calorie...
|
|
|
US20090163453 |
Prevention and Treatment of Gastrointestinal and Bladder Disorders Associated with Chemotherapy or Radiation Therapy Using Active Vitamin D Compounds
The present invention relates to a method for preventing, treating, or ameliorating gastrointestinal and bladder disorders in a patient receiving a chemotherapy or radiation therapy comprising...
|
|
|
US20090163452 |
COMPOSITIONS AND METHODS FOR LOWERING SERUM CHOLESTEROL
The invention provides a method for lowering circulating LDL-cholesterol or total cholesterol in a human in need thereof, comprising: orally administering to the human a therapeutically effective...
|
|
|
US20090137536 |
METHOD FOR TREATING AND PREVENTING HYPERPARATHYROIDISM
This invention relates to a method for treating or preventing hyperthyroidism associated with aging and/or with Aging-Related Vitamin D Deficiency (ARVDD) syndrome by administering a sufficient...
|
|
|
US20090136592 |
Vitamin preparation
Two-phase preparation for temporally gradual administration comprising
a) a phase (A) comprising water soluble vitamins and/or the corresponding provitamins, wherein phase (A) does not...
|
|
|
US20090131379 |
VITAMIN D RECEPTOR ACTIVATORS AND METHODS OF MAKING
The invention relates to compounds that are vitamin D receptor activators, compositions comprising such compounds, methods of using such compounds and compositions, processes for preparing such...
|
|
|
US20090131378 |
VITAMIN D DERIVATIVES ACTIVE ON THE VITAMIN D NUCLEAR RECEPTOR, PREPARATION AND USES THEREOF
The invention relates to vitamin D derivatives and their uses, particularly in the pharmaceutical industry. The invention discloses compounds having different interesting biological properties,...
|
|
|
US20090118244 |
BENZODIAZEPINONE COMPOUNDS USEFUL IN THE TREATMENT OF SKIN CONDITIONS
The present invention provides a family of benzodiazepinone compounds and pharmaceutical compositions thereof. The present invention also provides methods of treating certain skin conditions, e.g.,...
|
|
|
US20090111779 |
METHODS OF USE FOR 2,5-DIHYDROXYBENZENE SULFONIC ACID COMPOUNDS FOR THE TREATMENT OF CANCER, ROSACEA AND PSORIASIS
The invention describes compositions and methods of use for 2,5-dihydroxybenzene sulfonic acid compounds and pharmaceutically acceptable salts thereof. The invention provides methods for (a)...
|
|
|
US20090105198 |
NOVEL ESTROGENIC COMPOUNDS
Novel estrogenic compounds of Formula I are provided.
wherein the bond represented by the wavy line may be a single or double bond such that when the wavy line is a single bond, R 1 is selected...
|
|
|
US20090099141 |
COMPOSITIONS AND METHODS FOR TREATING VITAMIN D DEFICIENCIES
The present invention provides for: (a) an oral dosage of vitamin D3 for humans sufficient to maintain a serum level above a minimally sufficient level and below a toxic level when administered...
|
|
|
US20090099140 |
20-Alkyl, Gemini Vitamin D3 Compounds and Methods of Use Thereof
The invention provides 20-alkyl Gemini vitamin D 3 compounds, methods for using the compounds to treat vitamin D 3 associated states and pharmaceutical compositions containing the compounds.
|
|
|
US20090098065 |
COMPOSITION AND METHODS FOR THE TREATMENT OF SKIN DISORDERS
Methods and pharmaceutical compositions for use in the treatment of benign or malignant proliferative pathologies are disclosed. The methods involve the topical administration of nicotinamide or a...
|
|
|
US20090093445 |
RELEASE REAGENT FOR VITAMIN D COMPOUNDS
The present invention concerns a reagent composition for releasing vitamin D compounds bound to vitamin D-binding protein, a method for the detection of a 25-hydroxyvitamin D compound in which the...
|
|
|
US20090093444 |
Cathepsin Cysteine Protease Inhibitors
This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for...
|
|
|
US20090088373 |
USE OF COMPOSITIONS TO ENHANCE INNATE IMMUNE RESPONSE
The present invention discloses methods of using of compounds for the enhancement of the innate immune system of a patient. In particular, the active compounds of the present invention include at...
|
|
|
US20090082317 |
LOW-CALCEMIC 16,23-DIENE 25-OXIME ANALOGS OF 1ALPHA,25-DIHYDROXY VITAMIN D3
The present invention provides novel 16,23-diene 25-oxime ether analogs of 1,25-dihydroxy vitamin D3, compositions comprising these compounds and methods of using these compounds as inhibitors of...
|
|
|
US20090081194 |
COMPOSITIONS AND METHODS FOR REDUCING RISK OF DEVELOPMENT, OR SEVERITY, OF INAPPROPRIATE IMMUNE RESPONSE IN EYES
A composition for reducing the risk of development, or severity, of an inappropriate immune response in an eye comprises an antagonist to at least a human TLR, an antagonist to at least a...
|
|
|
US20090075953 |
DEUTERIUM-ENRICHED ED-71
The present application describes deuterium-enriched ED-71, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
|
|
|
US20090069276 |
Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin D compounds or mimics thereof
The present invention relates to a method for preventing, treating or ameliorating pulmonary disorders in a patient receiving a chemotherapeutic or radiotherapeutic agent or treatment comprising...
|
|
|
US20090068190 |
ANTI-PROLIFERATIVE COMBINATIONS
Combinations of a polyunsaturated fatty acid and diindolylmethane and pharmaceutical composition containing such combinations. Further provided are combinations including a polyunsaturated fatty...
|
|
|
US20090061048 |
DELIVERY AND CONTROLLED RELEASE OF ENCAPSULATED LIPOPHILIC NUTRIENTS
A complex coacervate delivery system is provided which encapsulates lipophilic nutrients such as, for example, fish oils high in omega-3 fatty acids. The complex coacervate delivery system protects...
|
|
|
US20090028930 |
BRUISE AMELIORATION COMPOSITION AND METHOD OF USE
A bruise amelioration composition that can be applied for one hour to an affected site, such as a bruise, contusion or blister, in the form of a gel, liquid or adhesive bandage. The composition...
|
|
|
US20090022792 |
Vitamin D content uniformity in pharmaceutical dosage forms
New dosage forms of vitamin D and calcium carbonate having improved content uniformity are described. The improvements are realized through modifications to the formulation, the raw material...
|
|
|
US20090018058 |
Vitamin D Receptor Modulators
The present invention relates to novel, non-secosteroidal, diaryl compounds with vitamin D receptor (VDR) modulating and psoriasis.
|
|
|
US20090017136 |
Formulation to prevent and treat fibromyalgia, depression and other muscle and nervous system disorders
The formulation provides for the treatment and prevention of fibromyalgia, depression and other muscle and nervous system disorders. The formulation combines Coenzyme Q10, vitamin B1,...
|
|
|
US20090012018 |
Inhibition of pancretic cancer cell growth
The present invention relates to compositions and methods for inhibition of signal transduction pathways in cancer cells. In particular, the present invention provides methods and compositions...
|
|
|
US20090004304 |
COMPOSITION COMPRISING BIOACTIVE SUBSTANCE
The present invention provides a powder superior in water-dispersibility/solubility, workability and tabletability, which contains an oil component containing a bioactive substance, a water-soluble...
|
|
|
US20090004232 |
BIOACTIVE PHARMACEUTICAL/COSMETIC COMPOSITIONS AND MIXED SOLUBILIZATION PROCESS FOR THE FORMULATION THEREOF
Physically stable pharmaceutical/cosmetic compositions contain at least one hydrophilic phase, at least one lipophilic phase and at least one active principle, e.g., at least one steroidal...
|